A detailed history of Wellspring Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wellspring Financial Advisors, LLC holds 2,954 shares of ABBV stock, worth $518,072. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,954
Previous 3,453 14.45%
Holding current value
$518,072
Previous $592 Million 1.5%
% of portfolio
0.07%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $81,756 - $99,465
-499 Reduced 14.45%
2,954 $583 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $102,161 - $119,301
660 Added 23.63%
3,453 $592 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $43,151 - $49,167
270 Added 10.7%
2,793 $509 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $22,566 - $25,415
-164 Reduced 6.1%
2,523 $391 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $48,893 - $56,601
-366 Reduced 11.99%
2,687 $401 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $26,236 - $32,650
198 Added 6.94%
3,053 $411 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $8,821 - $10,158
-61 Reduced 2.09%
2,855 $455 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $13,139 - $15,757
95 Added 3.37%
2,916 $471,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2,281 - $2,616
17 Added 0.61%
2,821 $379,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $11,697 - $14,871
-85 Reduced 2.94%
2,804 $429,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $2,375 - $2,947
18 Added 0.63%
2,889 $468,000
Q4 2021

Jan 03, 2022

BUY
$107.43 - $135.93 $9,346 - $11,825
87 Added 3.13%
2,871 $389,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $2,128 - $2,415
20 Added 0.72%
2,784 $300,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $290,800 - $323,968
2,764 New
2,764 $311,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $278,562 - $306,664
-2,723 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $885 - $1,195
11 Added 0.41%
2,723 $292,000
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $515 - $604
6 Added 0.22%
2,712 $238,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $198,539 - $265,675
2,706 New
2,706 $266,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wellspring Financial Advisors, LLC Portfolio

Follow Wellspring Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellspring Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellspring Financial Advisors, LLC with notifications on news.